Registry for understanding chronic subdural hematoma
Registry of Chronic Subdural Hematoma
Erasmus Medical Center · NCT06759428
This study is looking to gather information from adults with chronic subdural hematoma to see how different treatments work and improve care for future patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Erasmus Medical Center (other) |
| Locations | 2 sites (Amsterdam and 1 other locations) |
| Trial ID | NCT06759428 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather detailed information on chronic subdural hematoma (CSDH) by examining patient characteristics at diagnosis, treatment strategies employed, and outcomes following treatment. It will involve adult patients diagnosed with CSDH who will receive standard care and participate in a follow-up telephone interview three months post-treatment. The study seeks to address variability in management practices and improve evidence-based guidelines for CSDH treatment.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have been diagnosed with chronic subdural hematoma.
Not a fit: Patients who do not consent to participate in the registry will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of CSDH management and improve patient outcomes through better-informed treatment guidelines.
How similar studies have performed: While there is ongoing research in the field, this registry approach is novel in its focus on observational data collection for CSDH management.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with CSDH * 18 years or older Exclusion Criteria: * Patients who do not consent to participate in the registry
Where this trial is running
Amsterdam and 1 other locations
- Amsterdam UMC — Amsterdam, Netherlands (RECRUITING)
- Erasmus MC — Rotterdam, Netherlands (RECRUITING)
Study contacts
- Principal investigator: Ruben Dammers — Erasmus Medical Center
- Study coordinator: Rahman Fakhry
- Email: r.fakhry@erasmusmc.nl
- Phone: +31 10 7043507
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Chronic Subdural Hematoma, Registry, Chronic subdural hematoma, Traumatic Brain Injury, Treatment outcome, Burr hole drainage, modified Rankin Scale